Executive record
Keith Regnante
Most recent record: Keros Therapeutics, Inc. names Annita Tanini interim CFO (named as the outgoing officer), effective August 4, 2026. See Keros Therapeutics, Inc..
1 verified record
This page lists only verified filing records that name Keith Regnante; it is not a career history. Corrections: the corrections page.